Update on the role of antipsychotics in the treatment of Tourette syndrome

Código QR

Update on the role of antipsychotics in the treatment of Tourette syndrome

Daniel Huys, Katja Hardenacke, Pia Poppe, Christina Bartsch, Burak Baskin, Jens KuhnDepartment of Psychiatry and Psychotherapy, University of Cologne, Cologne, GermanyHead: Prof. Dr. Joachim Klosterk&ouml;tterAbstract: Tourette syndrome (TS) is a neuropsychiatric disorder with typical onset...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Huys D, Hardenacke K, Poppe P, Bartsch C, Baskin B, Kuhn J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/856b97fb9f904523b5cddfa2f702ed5a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Are there distinct subtypes in Tourette syndrome? Pure-Tourette syndrome versus Tourette syndrome-plus, and simple versus complex tics
por: Eapen V, et al.
Publicado: (2015)

Levetiracetam as an alternative therapy for Tourette syndrome
por: MA Mart&iacute;nez-Granero, et al.
Publicado: (2010)

Neurosurgical strategies for Gilles de la Tourette&rsquo;s syndrome
por: Karim Mukhida, et al.
Publicado: (2008)

Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
por: Izchak Kohen, et al.
Publicado: (2010)

Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka M, et al.
Publicado: (2015)

Update on treatment of partial onset epilepsy: role of eslicarbazepine
por: Markus Rauchenzauner, et al.
Publicado: (2010)

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
por: Xinhua&nbsp;S Ren, et al.
Publicado: (2009)

Influence of drug treatment with antidepressants and antipsychotics on plasma urea levels
por: Lozano Ortiz R
Publicado: (2012)

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka M, et al.
Publicado: (2015)

Update on treatment options for Lambert&ndash;Eaton myasthenic syndrome: focus on use of amifampridine
por: Lindquist S, et al.
Publicado: (2011)

Deep brain stimulation in Tourette’s syndrome: evidence to date
por: Casagrande SCB, et al.
Publicado: (2019)

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia
por: Ascher-Svanum H, et al.
Publicado: (2012)

Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder
por: Azekawa T, et al.
Publicado: (2011)

Gastrodin Attenuates Tourette Syndrome by Regulating EAATs and NMDA Receptors in the Striatum of Rats
por: Sun X, et al.
Publicado: (2021)

Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
por: Carl&nbsp;E Stafstrom
Publicado: (2009)

The comparison of glucose and lipid metabolism parameters in drug-naïve, antipsychotic-treated, and antipsychotic discontinuation patients with schizophrenia
por: Wu X, et al.
Publicado: (2014)

The influence of atypical antipsychotic drugs on sexual function
por: Just MJ
Publicado: (2015)

Update on optimal use of lisdexamfetamine in the treatment of ADHD
por: Madaan V, et al.
Publicado: (2013)

Pregabalin for the treatment of generalized anxiety disorder: an update
por: Baldwin DS, et al.
Publicado: (2013)

Family-Based Analysis Combined with Case–Controls Study Implicate Roles of PCNT in Tourette Syndrome
por: Liu W, et al.
Publicado: (2020)

Profile of lacosamide and its role in the long-term treatment of epilepsy: a perspective from the updated NICE guideline
por: Delgado Nunes V, et al.
Publicado: (2013)

Long-acting injectable antipsychotics: focus on olanzapine pamoate
por: JP Lindenmayer
Publicado: (2010)

The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
por: Gro&scaron;ić V, et al.
Publicado: (2014)

Update on ropinirole in the treatment of Parkinson&rsquo;s disease
por: Holly A Shill, et al.
Publicado: (2008)

Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone
por: Hong Liu-Seifert, et al.
Publicado: (2009)

Update on the use of pramipexole in the treatment of Parkinson&rsquo;s disease
por: Radu Constantinescu
Publicado: (2008)

The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study
por: Hashimoto K, et al.
Publicado: (2014)

Social communication deficits and restricted repetitive behavior symptoms in Tourette syndrome
por: Eapen V, et al.
Publicado: (2019)

Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
por: Prashant Gajwani, et al.
Publicado: (2007)

Update on the treatment of Parkinson’s disease psychosis: role of pimavanserin
por: Combs BL, et al.
Publicado: (2017)

Tetrabenazine-induced oculogyric crisis – a rare complication in the treatment of Gilles de la Tourette syndrome
por: Janik P, et al.
Publicado: (2016)

Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia
por: Goto N, et al.
Publicado: (2012)

A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice
por: Bod&eacute;n R, et al.
Publicado: (2013)

Pharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for clinicians
por: Adriana Foster, et al.
Publicado: (2007)

Gelastic seizures associated with hypothalamic hamartomas. An update in the clinical presentation, diagnosis and treatment
por: Jos&eacute; F. Tellez-Zenteno, et al.
Publicado: (2008)

Altered heart rate dynamics associated with antipsychotic-induced subjective restlessness in patients with schizophrenia
por: Kim JH, et al.
Publicado: (2013)

Serum substance P levels in patients with chronic schizophrenia treated with typical or atypical antipsychotics
por: Takahiko Nagamine
Publicado: (2008)

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East
por: Alkhadhari S, et al.
Publicado: (2015)

Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
por: Adam UU, et al.
Publicado: (2014)

Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review
por: Xu H, et al.
Publicado: (2019)